MOLECULAR CANCER THERAPEUTICS

期刊名
MOLECULAR CANCER THERAPEUTICS

MOL CANCER THER

ISSN / eISSN
1535-7163 / 1538-8514
目标和范围
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.
研究方向

肿瘤学

CiteScore
10.30 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Oncology Q1 #48/366
Medicine - Cancer Research Q1 #41/214
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
ONCOLOGY - SCIE Q2
H-index
157
出版国家或地区
UNITED STATES
出版商
American Association for Cancer Research Inc.
出版周期
Monthly
出版年份
2001
年文章数
160
Open Access
NO
通讯方式
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
The magazine under the American Cancer Society has fewer publications by Chinese people, making it more difficult to submit. The reviewers provide constructive feedback, and making improvements according to their suggestions has enhanced the experimental articles.
2022-07-02
First review took one month, second review took one and a half months. From submission to online publication, it took a total of eight months (07/2020 - 03/2021).
2021-03-18

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started